Patents by Inventor Sten Wie

Sten Wie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
    Patent number: 11376247
    Abstract: Methods for inducing the regeneration of non-cancerous tissues in a cancer patient undergoing radiotherapy and/or chemotherapy using continuous administration of tyrosine kinase inhibitors for at least 90 days following a cancer treatment in the patient.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: July 5, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Mary Reyland, Sten Wie
  • TYROSINE KINASE INHIBITORS REGENERATE NON-CANCEROUS TISSUE AFTER CANCER THERAPY
    Publication number: 20200138807
    Abstract: Methods for inducing the regeneration of non-cancerous tissues in a cancer patient undergoing radiotherapy and/or chemotherapy using continuous administration of tyrosine kinase inhibitors for at least 90 days following a cancer treatment in the patient.
    Type: Application
    Filed: June 5, 2018
    Publication date: May 7, 2020
    Inventors: Mary Reyland, Sten Wie
  • Use of tyrosine kinase inhibitor in cancer treatment
    Patent number: 10076520
    Abstract: The present invention provides methods for reducing apoptosis of non-cancerous cells during a cancer treatment and beneficial effects associated with reducing such apoptosis. In particular, methods of the invention comprise administering a tyrosine kinase inhibitor to a cancer patient who is undergoing cancer treatment in order to reduce apoptosis of non-cancerous cells.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: September 18, 2018
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Mary E. Reyland, Sten Wie, James DeGregori
  • USE OF TYROSINE KINASE INHIBITOR IN CANCER TREATMENT
    Publication number: 20160228436
    Abstract: The present invention provides methods for reducing apoptosis of non-cancerous cells during a cancer treatment and beneficial effects associated with reducing such apoptosis. In particular, methods of the invention comprise administering a tyrosine kinase inhibitor to a cancer patient who is undergoing cancer treatment in order to reduce apoptosis of non-cancerous cells.
    Type: Application
    Filed: October 17, 2014
    Publication date: August 11, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Mary E. Reyland, Sten Wie, James DeGregori